| Autor: |
Tarricone A; State University of New York Downstate, Brooklyn, NY., Gee A; †Icahn School of Medicine at the Mount Sinai Hospital, New York, NY., Mata K; ‡Lenox Hill Hospital at Northwell Health, New York, NY., Axman W; §NYC Health and Hospitals/Queens Hospital Center, Queens, NY., Buricea C; §NYC Health and Hospitals/Queens Hospital Center, Queens, NY., Trepal M; State University of New York Downstate, Brooklyn, NY., Krishnan P; †Icahn School of Medicine at the Mount Sinai Hospital, New York, NY. |
| Abstrakt: |
Squamous cell carcinoma is a malignant tumor that is most commonly found on the head and neck. The current global incidence of squamous cell carcinoma at any site is estimated to be more than 1 million cases per year, with a reported 3-year mortality rate of 30%. Recurrence of squamous cell carcinoma at any site is estimated to be 15% to 50% and has been associated with greater rates of infiltration, perineural invasion, and mortality. Recent studies have shown lower-extremity squamous cell carcinoma to be distinct from squamous cell carcinoma at any site with histologic and clinical differences. Lower-extremity squamous cell carcinoma is suggestively less aggressive and carries less risk of metastasis. However, lower-extremity squamous cell carcinoma prevalence, mortality, and recurrence rates have not been extensively studied. The present report depicts a case of recurrent squamous cell carcinoma originating in 2006 in the dorsal forefoot and provides the clinical management of subsequent recurrence episodes, with excisions from 2015 and 2020. |
